AssetMark Inc’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
AssetMark Inc's IRMD Position: Q2 2026 in Review
AssetMark Inc held its iRadimed (IRMD) position steady in Q2 2026 at 47 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.
AssetMark Inc first reported a position in IRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.52K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- AssetMark Inc held 47 shares of iRadimed worth $4.49K as of Q2 2026.
- AssetMark Inc left its iRadimed share count unchanged in Q2 2026.
- iRadimed made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2726 holding.
- AssetMark Inc first reported a position in iRadimed in Q1 2025 and has held it in 6 quarters since.
- AssetMark Inc's iRadimed position peaked at $4.52K in Q1 2026.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.